West Branch Capital LLC Eli Lilly & CO Transaction History

West Branch Capital LLC

  • $297 Million
  • Q4 2024

A detailed history of West Branch Capital LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, West Branch Capital LLC holds 5,124 shares of LLY stock, worth $3.93 Million. This represents 1.33% of its overall portfolio holdings.

Number of Shares
5,124
Previous 4,512 13.56%
Holding current value
$3.93 Million
Previous $4 Million 1.05%
% of portfolio
1.33%
Previous 1.46%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 17, 2025
BUY
$727.2 - $932.06 $445,046 - $570,420
612 Added 13.56%
5,124 $3.96 Million
Q3 2024

Oct 18, 2024
BUY
$772.14 - $960.02 $140,529 - $174,723
182 Added 4.2%
4,512 $4 Million
Q2 2024

Jul 26, 2024
BUY
$724.87 - $909.04 $76,111 - $95,449
105 Added 2.49%
4,330 $3.92 Million
Q1 2024

Apr 23, 2024
BUY
$592.2 - $792.28 $374,270 - $500,720
632 Added 17.59%
4,225 $3.29 Million
Q4 2023

Jan 19, 2024
BUY
$525.19 - $619.13 $258,393 - $304,611
492 Added 15.87%
3,593 $2.09 Million
Q3 2023

Oct 20, 2023
BUY
$434.7 - $599.3 $19,996 - $27,567
46 Added 1.51%
3,101 $1.67 Million
Q2 2023

Aug 04, 2023
BUY
$350.74 - $468.98 $65,237 - $87,230
186 Added 6.48%
3,055 $1.43 Million
Q1 2023

Apr 20, 2023
SELL
$310.63 - $364.82 $6,523 - $7,661
-21 Reduced 0.73%
2,869 $985,000
Q4 2022

Jan 27, 2023
BUY
$321.55 - $374.67 $321 - $374
1 Added 0.03%
2,890 $0
Q3 2022

Oct 19, 2022
BUY
$296.48 - $337.87 $13,341 - $15,204
45 Added 1.58%
2,889 $934,000
Q2 2022

Jul 28, 2022
SELL
$278.73 - $327.27 $278 - $327
-1 Reduced 0.04%
2,844 $922,000
Q1 2022

May 03, 2022
SELL
$234.69 - $291.66 $49,988 - $62,123
-213 Reduced 6.97%
2,845 $815,000
Q4 2021

Jan 24, 2022
BUY
$224.85 - $279.04 $123,217 - $152,913
548 Added 21.83%
3,058 $845,000
Q3 2021

Nov 09, 2021
BUY
$221.6 - $272.71 $41,660 - $51,269
188 Added 8.1%
2,510 $580,000
Q2 2021

Aug 17, 2021
BUY
$180.55 - $233.54 $150,217 - $194,305
832 Added 55.84%
2,322 $532,000
Q1 2021

May 14, 2021
BUY
$164.32 - $212.72 $244,836 - $316,952
1,490 New
1,490 $278,000
Q4 2020

Feb 08, 2021
SELL
$130.46 - $172.63 $578,851 - $765,959
-4,437 Closed
0 $0
Q3 2020

Oct 13, 2020
BUY
$146.22 - $169.13 $48,691 - $56,320
333 Added 8.11%
4,437 $657,000
Q2 2020

Jul 08, 2020
BUY
$136.42 - $164.18 $559,867 - $673,794
4,104 New
4,104 $674,000

Others Institutions Holding LLY

# of Institutions
4,031
Shares Held
739M
Call Options Held
8.27M
Put Options Held
10.5M
View Full List

About ELI LILLY & Co

LLY Quotes by TradingView
  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $728B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track West Branch Capital LLC Portfolio

Follow West Branch Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of West Branch Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on West Branch Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email